Cargando…
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Depression and cognitive disorders are diseases with complex and not-fully understood etiology. Unfortunately, the COVID-19 pandemic dramatically increased the prevalence of both conditions. Since the current treatments are inadequate in many patients, there is a constant need for discovering new co...
Autores principales: | Sałaciak, Kinga, Pytka, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559442/ https://www.ncbi.nlm.nih.gov/pubmed/34736882 http://dx.doi.org/10.1016/j.neubiorev.2021.10.037 |
Ejemplares similares
-
The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders
por: Sałaciak, Kinga, et al.
Publicado: (2021) -
The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α(1)-Adrenolytic Properties
por: Lustyk, Klaudia, et al.
Publicado: (2022) -
The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia
por: Lustyk, Klaudia, et al.
Publicado: (2021) -
The selective 5-HT(1A) receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress
por: Głuch-Lutwin, Monika, et al.
Publicado: (2021) -
Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT(1A) and D(2) Receptors
por: Sałaciak, Kinga, et al.
Publicado: (2021)